Furthermore, while the association between Wnt5a and RVEF was particularly strong in patients with more severe RV dysfunction, the lack of this association for sFRP3 could indicate that it is unable to adequately antagonize Wnt5a in DCM patients with end-stage disease. This evidence concerns the gene FRZB and familial dilated cardiomyopathy.